These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1141 related articles for article (PubMed ID: 8004750)

  • 1. Antitumor activity of halogen analogs of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide, and trofosfamide.
    Struck RF; Schmid SM; Waud WR
    Cancer Chemother Pharmacol; 1994; 34(3):191-6. PubMed ID: 8004750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
    Struck RF; Dykes DJ; Corbett TH; Suling WJ; Trader MW
    Br J Cancer; 1983 Jan; 47(1):15-26. PubMed ID: 6821629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observations on the effects of cyclophosphamide, phosphoramide mustard and some activated oxazaphosphorines on murine L1210 leukemia.
    Zaharko DS; Covey JM; Hörpel G
    Invest New Drugs; 1984; 2(2):149-54. PubMed ID: 6469508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemically stable, lipophilic prodrugs of phosphoramide mustard as potential anticancer agents.
    Kwon CH; Moon KY; Baturay N; Shirota FN
    J Med Chem; 1991 Feb; 34(2):588-92. PubMed ID: 1995881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
    Chang TK; Waxman DJ
    Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro cytotoxicity testing of new generation oxazaphosphorines against human histiocytic lymphoma cells.
    Opydo-Chanek M; Mazur L; Stojak M
    Indian J Exp Biol; 2013 Aug; 51(8):615-22. PubMed ID: 24228385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of cyclophosphamide, isophosphamide, 4-methylcyclophosphamide, and phosphoramide mustard on murine hematopoietic and immunocompetent cells.
    Sensenbrenner LL; Marini JJ; Colvin M
    J Natl Cancer Inst; 1979 Apr; 62(4):975-81. PubMed ID: 285298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isophosphoramide mustard analogues as prodrugs for anticancer gene-directed enzyme-prodrug therapy (GDEPT).
    Misiura K; Szymanowicz D; Kuśnierczyk H; Wietrzyk J; Opolski A
    Acta Biochim Pol; 2002; 49(1):169-76. PubMed ID: 12136937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates.
    Kuśnierczyk H; Radzikowski C; Paprocka M; Budzyński W; Rak J; Kinas R; Misiura K; Stec W
    J Immunopharmacol; 1986; 8(4):455-80. PubMed ID: 3805744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antitumor properties of activated cyclophosphamide analogues.
    Borch RF; Canute GW
    J Med Chem; 1991 Oct; 34(10):3044-52. PubMed ID: 1920355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines.
    Jain M; Fan J; Baturay NZ; Kwon CH
    J Med Chem; 2004 Jul; 47(15):3843-52. PubMed ID: 15239662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxazaphosphorines combined with immune checkpoint blockers: dose-dependent tuning between immune and cytotoxic effects.
    Delahousse J; Skarbek C; Desbois M; Perfettini JL; Chaput N; Paci A
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32784216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 4-hydroperoxy derivatives of ifosfamide and trofosfamide by direct ozonation and preliminary antitumor evaluation in vivo.
    Hohorst HJ; Peter G; Struck RF
    Cancer Res; 1976 Jul; 36(7 PT 1):2278-81. PubMed ID: 945124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 31P NMR studies of the kinetics of bisalkylation by isophosphoramide mustard: comparisons with phosphoramide mustard.
    Boal JH; Williamson M; Boyd VL; Ludeman SM; Egan W
    J Med Chem; 1989 Aug; 32(8):1768-73. PubMed ID: 2754703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-linking of DNA in L1210 cells and nuclei treated with cyclophosphamide and phosphoramide mustard.
    Surya YA; Rosenfeld JM; Hillcoat BL
    Cancer Treat Rep; 1978 Jan; 62(1):23-9. PubMed ID: 564237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphate prodrugs of isophosphoramide mustard.
    Misiura K; Szymanowicz D; Wietrzyk J; Opolski A
    Acta Pol Pharm; 2003; 60(2):109-12. PubMed ID: 13678316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antineoplastic activity of a novel series of phosphoramide mustard analogues of pyrimidine deoxyribonucleosides.
    Lin TS; Fischer PH; Prusoff WH
    J Med Chem; 1980 Nov; 23(11):1235-7. PubMed ID: 7452673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of DNA breakage in U937 cells by oxazaphosphorines.
    Mazur L; Opydo-Chanek M; Stojak M; Baran J; Niemeyer U
    Folia Biol (Krakow); 2010; 58(1-2):15-20. PubMed ID: 20420190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cytotoxic action of iphosphamide and cyclophosphamide.
    Phelan ET; Vietti TJ; Valeriote FA; Coulter D
    Anticancer Res; 1981; 1(3):149-54. PubMed ID: 7342853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of glufosfamide in childhood acute leukemia.
    Styczynski J; Wysocki M; Kurylak A; Juraszewska E; Malinowska I; Stanczak E; Płoszynska A; Stefaniak J; Mazur B; Szczepanski T; Ras M
    Anticancer Res; 2002; 22(1A):247-50. PubMed ID: 12017297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.